Stryker公司报告,Q2收入和收入超过预期,预计2025年增长强劲。 Stryker Corporation reports Q2 revenue and earnings above expectations, projecting strong growth for 2025.

Stryker公司是一家医疗技术公司,其Q2收入和收入超过了分析师的预期,分别上升11%和11.4%。 Stryker Corporation, a medical technology firm, saw its Q2 revenue and earnings exceed analyst expectations, rising 11% and 11.4%, respectively. 该公司预测2025年有机净销售额增长9.5%至10.0%,调整后人均收入13.40至13.60美元。 The company forecasts 2025 organic net sales growth of 9.5% to 10.0% and adjusted earnings per share of $13.40 to $13.60. Stryker的成功归功于其核心部分、收购和新产品的强劲需求,尽管其运营和监管成本不断增加。 Stryker's success is attributed to strong demand in its core segments, acquisitions, and new products, though it faces growing operating and regulatory costs. 在第一季度,PNC金融服务公司在Stryker的股票存量增加了1.3%。 PNC Financial Services increased its stock position in Stryker by 1.3% in the first quarter.